EFFECTIVE THERAPY OF HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED ANEMIA WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN DESPITE HIGH ENDOGENOUS ERYTHROPOIETIN

A 32-year-old woman with human immunodeficiency virus (HIV) infection and progressive anemia presented to University Hospital with a hemoglobin of 3.4 g/dl. Because of her religious beliefs, she refused transfusion, and no iron or vitamin deficiency was found. She responded to recombinant human erythropoietin 150 U/kg intramuscularly thrice weekly with a rise in hemoglobin to 9.3 g/dl by 3 months of treatment. The serum erythropoietin level before treatment was markedly elevated at 1,340 mU/ml.